|
Section b3: date of event: unknown; requested but not provided.The best estimate date is prior to apr 10, 2024.Section h3: the device was not returned for evaluation; therefore, a failure analysis of the complaint device cannot be completed.A review of the device history record and complaint history for production order for this device will be performed.Upon completion of the review, if there is any further relevant information a supplemental medwatch will be filed.Attempts were made to obtain the missing information; however, no additional information has been received.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
|
|
In follow-up, the healthcare provider information was provided; therefore, section e1 is being updated in this supplemental report.Additionally, the product was returned to the manufacturing site for evaluation.Additional information: section d9: device available for evaluation? yes.Section d9: date returned to manufacturer: may 16, 2024.Section e1: dr.(b)(6).Section e2: health professional?: yes.Section e3: occupation: physician.Section h3: evaluated by manufacturer: yes.Device evaluation: visual inspection was performed on the suspect product and found the lens was cut in half.No issues that would have caused or contributed to the complaint event were identified.No further evaluation was performed.The complaint issue "unspecified injury" and "pt-explant " was not identified during product evaluation.The other observed issues during the product evaluation could not be confirmed to be related to the manufacturing or design process.Conclusion: based on the complaint investigation results, the product was released within specifications.No product deficiency or product malfunction could be identified.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
|
|
Additional information: through follow-up, it was learned that the patient had left eye visual complaints of distortion and lack of sharpness ultimately attributed to the toric lens.The patient's pre-operative visual acuity (va) was uncorrected 20/30 and corrected 20/25.The patient's post-operative va (post initial implant) was uncorrected 20/20-1, "blurry" and corrected 20/20, "still blurry".The targeted post-operative refraction was plano.There was no calculation issue.A non-johnson and johnson intraocular lens (iol) was implanted as replacement (+17.5 diopter).There was no patient injury.No additional medical or surgical intervention was required.The patient's post-operative va (post replacement implant) was uncorrected 20/20+ and corrected 20/20.The patient is happy with the exchange.The patient¿s date of birth, sex, gender, weight, race, ethnicity, date of event, implant date, explant date, and the initial reporter¿s email and telephone number were also provided.No further information was provided.Correction: based on the additional information received, section h6: health effect - clinical code 1845 - eye injury, which was reported on the initial mdr, is no longer applicable.Section h6: health effect - impact code 2271 - therapeutic response decreased and section h6: health effect - clinical code(s) 2140 - visual disturbances and 2137 - blurred vision have been added.This supplemental report is to capture this corrected information.The following fields have been updated accordingly: section a2: age and date of birth: (b)(6) 1945 section a3a: sex: male section a3b: gender: cisgender man/boy section a4: weight: 180 pound(s) section a5: ethnicity: not hispanic/latino section a6: race: white section b3: date of event: jan 25, 2024 section d6a: if implanted, give date: (b)(6) 2024 section d6b: if explanted, give date: (b)(6)2024 section e1: email address: (b)(6) section e1: telephone number: (b)(6) section h6: health effect - impact code 2271 - therapeutic response decreased section h6: health effect - clinical code 2140 - visual disturbances section h6: health effect - clinical code 2137 - blurred vision all pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
|